Prospects for the use of NK cells in immunotherapy of human cancer
Top Cited Papers
- 1 May 2007
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 7 (5) , 329-339
- https://doi.org/10.1038/nri2073
Abstract
Current insights into the molecular specificities that regulate natural killer (NK)-cell function suggest that it might be possible to design NK-cell-based immunotherapeutic strategies against human cancer. Here, we describe evidence for NK-cell targeting of human tumours and address crucial questions that, in our opinion, require consideration for the development of successful NK-cell-based therapies. Appropriately used, we predict that NK cells will have a role, both directly and in combination with other treatment modalities, in future treatment of cancer.Keywords
This publication has 138 references indexed in Scilit:
- Increased intensity lymphodepletion and adoptive immunotherapy—how far can we go?Nature Clinical Practice Oncology, 2006
- Activation and self‐tolerance of natural killer cellsImmunological Reviews, 2006
- Bortezomib and Depsipeptide Sensitize Tumors to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand: A Novel Method to Potentiate Natural Killer Cell Tumor CytotoxicityCancer Research, 2006
- Generation of Antitumor Responses by Genetic Modification of Primary Human T Cells with a Chimeric NKG2D ReceptorCancer Research, 2006
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Escape from immune- and nonimmune-mediated tumor surveillanceSeminars in Cancer Biology, 2006
- Cytokines in cancer immunity and immunotherapyImmunological Reviews, 2004
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- A new method for in vitro expansion of cytotoxic human CD3−CD56+ natural killer cellsHuman Immunology, 2001
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985